Taysha Gene Therapies, Inc. (TSHA)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS8776191061
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Taysha Gene Therapies, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:08. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Nov 2026 07:00 | -0.12 | -0.09 | +25.0% | Beat |
| 11 Aug 2026 16:00 | -0.11 | — | — | — |
| 06 May 2026 08:00 | -0.10 | -0.11 | -14.0% | Miss |
| 19 Mar 2026 08:00 | -0.10 | -0.07 | +25.3% | Beat |
| 04 Nov 2025 06:00 | -0.09 | -0.09 | +2.8% | Beat |
| 12 Aug 2025 08:00 | -0.07 | -0.08 | -12.5% | Miss |
| 15 May 2025 08:00 | -0.09 | -0.07 | +17.1% | Beat |
| 26 Feb 2025 08:00 | -0.08 | -0.07 | +15.4% | Beat |
| 13 Nov 2024 16:00 | -0.09 | -0.07 | +20.9% | Beat |
| 12 Aug 2024 08:00 | -0.10 | -0.09 | +14.8% | Beat |
| 14 May 2024 16:00 | -0.09 | -0.10 | -3.2% | Miss |
| 19 Mar 2024 16:00 | -0.10 | -0.28 | -187.4% | Miss |
| 14 Nov 2023 16:00 | -0.17 | -0.93 | -435.6% | Miss |
| 14 Aug 2023 07:00 | -0.31 | -0.38 | -23.2% | Miss |
| 11 May 2023 16:00 | -0.38 | -0.28 | +26.3% | Beat |
| 28 Mar 2023 16:00 | -0.34 | -0.34 | -0.9% | In line |
| 08 Nov 2022 07:00 | -0.82 | -0.64 | +21.5% | Beat |
| 11 Aug 2022 07:00 | -1.06 | -0.84 | +21.0% | Beat |
| 16 May 2022 07:00 | -1.10 | -1.31 | -18.6% | Miss |
| 31 Mar 2022 07:00 | -1.27 | -1.32 | -3.7% | Miss |
| 10 Nov 2021 07:00 | -1.09 | -1.35 | -23.7% | Miss |
| 16 Aug 2021 07:00 | -0.86 | -1.09 | -26.9% | Miss |
| 11 May 2021 07:00 | -0.65 | -0.87 | -33.2% | Miss |
| 03 Mar 2021 07:00 | -0.49 | -0.31 | +37.2% | Beat |
| 12 Nov 2020 16:00 | 0.07 | -1.28 | -2,069.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 9.8M | +17.3% | -109M | -1,115.3% | -0.34 | +5.6% | -93.8M |
| 2024 | 8.3M | -46.1% | -89.3M | -1,071.6% | -0.36 | +62.5% | -81.6M |
| 2023 | 15.5M | +517.5% | -111.6M | -722.1% | -0.96 | +74.6% | -80.4M |
| 2022 | 2.5M | — | -166M | -6,635.3% | -3.78 | — | -113.3M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 4.41 | 4.53 | 4.04 | 4.13 | -4.62% | 11,667,586 | |
| 02 Nov 2026 – 06 Nov 2026 | 4.30 | 4.45 | 3.92 | 4.33 | +4.84% | 17,692,300 | |
| 26 Oct 2026 – 30 Oct 2026 | 3.98 | 4.47 | 3.95 | 4.13 | +4.29% | 11,601,200 | |
| 19 Oct 2026 – 23 Oct 2026 | 3.66 | 4.27 | 3.65 | 3.96 | +9.39% | 25,951,700 | |
| 12 Oct 2026 – 16 Oct 2026 | 4.46 | 4.56 | 3.46 | 3.62 | -19.38% | 22,109,000 | |
| 05 Oct 2026 – 09 Oct 2026 | 4.64 | 4.64 | 4.26 | 4.49 | -3.02% | 23,018,300 | |
| 28 Sep 2026 – 02 Oct 2026 | 4.64 | 5.06 | 4.56 | 4.63 | -0.86% | 23,571,500 | |
| 21 Sep 2026 – 25 Sep 2026 | 5.07 | 5.22 | 4.66 | 4.67 | -6.97% | 20,554,100 | |
| 14 Sep 2026 – 18 Sep 2026 | 5.00 | 5.46 | 4.90 | 5.02 | 0.00% | 29,390,500 | |
| 08 Sep 2026 – 11 Sep 2026 | 5.57 | 5.58 | 4.98 | 5.02 | -10.36% | 8,212,500 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Taysha Gene Therapies Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 12 Nov 2026 21:14
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (opens in a new tab) 06 Nov 2026 13:00
- Taysha Gene Therapies to Release Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 12 (opens in a new tab) 05 Nov 2026 13:00
- Taysha Gene Therapies (TSHA) Stock Looks Rich Against Book Value (opens in a new tab) Simply Wall St. · 30 Oct 2026 08:14
- Does Early Rett Trial Success Change The Bull Case For Taysha Gene Therapies (TSHA)? (opens in a new tab) Simply Wall St. · 19 Oct 2026 03:07
- Taysha Gene Therapies (TSHA) Stock May Be Above Fair Value On Book Value (opens in a new tab) Simply Wall St. · 09 Oct 2026 19:12
- Taysha Gene Therapies (TSHA) Faces A Split Valuation Debate, Is It Really 66% Below Fair Value? (opens in a new tab) Simply Wall St. · 09 Oct 2026 08:15
- These 3 Risky Stocks Could Be Sitting on 100% Upside (opens in a new tab) MarketBeat · 07 Sep 2026 16:35
- Taysha Gene Therapies (TSHA) Q2 2026 Earnings Call (opens in a new tab) Motley Fool · 19 Aug 2026 00:13
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 4.21 USD
- Market cap
- 1.4B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow TSHA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.